Skip Navigation


European Heart Journal Advance Access originally published online on May 24, 2008
European Heart Journal 2008 29(12):1475-1477; doi:10.1093/eurheartj/ehn230
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/12/1475    most recent
ehn230v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schiele, F.
Right arrow Articles by Bassand, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiele, F.
Right arrow Articles by Bassand, J.-P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer?

Francois Schiele, Nicolas Meneveau and Jean-Pierre Bassand*

Department of Cardiology, University Hospital Jean Minjoz, 25000 Besançon, France

* Corresponding author. Tel: +33 381 668 539, Fax: +33 381 668 582, Email: jpbassan@univ-fcomte.fr

This editorial refers to ‘Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8’{dagger} by P. Widimsky et al., on page 1495

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

{dagger} doi:10.1093/eurheartj/ehn169 Back

The first 150 words of the full text of this article appear below.

Dual antiplatelet therapy is the mainstay of antiplatelet treatment in percutaneous coronary interventions (PCIs) with stent implantation, as well as in acute coronary syndromes (ACS) with and without ST segment elevation.1–3 In ACS, dual antiplatelet therapy has been shown to reduce the risk of death and myocardial infarction (MI), both at the initial phase and in the long term. In the setting of stent implantation, dual antiplatelet therapy has been shown to reduce the risk of major adverse cardiac events (MACEs) and stent thrombosis, as compared with various other antithrombotic regimens. Ticlopidine was the first thienopyridine to be used in the setting of stent implantation, but, over time, clopidogrel has proven to be better tolerated and more efficacious.4

However, clopidogrel is a prodrug, which . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8
Petr Widimsky, Zuzana Motovská, Stanislav Simek, Petr Kala, Radek Pudil, Frantisek Holm, Robert Petr, Dana Bílková, Hana Skalická, Petr Kuchynka, Martin Poloczek, Roman Miklík, Marek Maly, Michael Aschermann, and on behalf of the PRAGUE-8 trial Investigators
EHJ 2008 29: 1495-1503. [Abstract] [FREE Full Text]  

Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8
Petr Widimsky, Zuzana Motovská, Stanislav Simek, Petr Kala, Radek Pudil, Frantisek Holm, Robert Petr, Dana Bílková, Hana Skalická, Petr Kuchynka, Martin Poloczek, Roman Miklík, Marek Maly, Michael Aschermann, and on behalf of the PRAGUE-8 trial Investigators
EHJ 2008 29: 1495-1503. [Abstract] [FREE Full Text]